For two years, Hikma Pharmaceuticals generously funded AT Forum. That funding ended at the end of 2022, but AT Forum still values the company’s – and all companies’ – contributions to the field. Please keep reading! Again, thank you Hikma. These have been difficult times for many in the opioid use disorder treatment field. As AATOD’s Mark Parrino told us recently, a ship at sea can still weather the storm if the captains know how and don’t panic.